Edition:
India

American Renal Associates Holdings Inc (ARA.N)

ARA.N on New York Stock Exchange

13.03USD
17 Nov 2017
Change (% chg)

$0.41 (+3.25%)
Prev Close
$12.62
Open
$12.61
Day's High
$13.17
Day's Low
$12.54
Volume
84,969
Avg. Vol
47,690
52-wk High
$25.25
52-wk Low
$9.91

Latest Key Developments (Source: Significant Developments)

American Renal Associates Holdings reports adj. EPS $0.19
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - American Renal Associates Holdings Inc :Announces third quarter 2017 results.Q3 adjusted earnings per share $0.19.Q3 earnings per share view $0.16 -- Thomson Reuters I/B/E/S.Qtrly ‍net patient service operating revenues decreased 2.7 pct to $187.7 million​.‍Reiterating its prior guidance for 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million​.‍Company is reiterating its prior guidance for 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million​.  Full Article

American Renal Associates Q2 loss per share $0.75
Wednesday, 10 Aug 2016 

American Renal Associates Holdings Inc : American Renal Associates Holdings Inc announces second quarter 2016 results . Q2 loss per share $0.75 . Q2 adjusted earnings per share $0.26 . Q2 earnings per share view $0.22 -- Thomson Reuters I/B/E/S . Net patient service operating revenues for Q2 of 2016 were $185.6 million, an increase of 14.9% .Q2 revenue view $177.9 million -- Thomson Reuters I/B/E/S.  Full Article

American Renal Associates Q2 loss per share $0.75
Wednesday, 10 Aug 2016 

American Renal Associates Holdings Inc : American Renal Associates Holdings Inc announces second quarter 2016 results . Q2 loss per share $0.75 . Q2 adjusted earnings per share $0.26 . Q2 earnings per share view $0.22 -- Thomson Reuters I/B/E/S . Net patient service operating revenues for Q2 of 2016 were $185.6 million, an increase of 14.9% .Q2 revenue view $177.9 million -- Thomson Reuters I/B/E/S.  Full Article

American Renal Associates receives complaint by UnitedHealth affiliates
Tuesday, 5 Jul 2016 

American Renal Associates: Says on July 1, 2016, received a complaint filed by three affiliates of UnitedHealth Group Inc in Florida - SEC filing . Complaint identifies about $1.9 million of payments made to 12 of co's facilities that united claims were "improper" . Says complaint seeks monetary damages and injunctive relief .Complaint relates to 27 patients who have received dialysis at 12 ARA facilities in Florida and Ohio.  Full Article

American Renal Associates reports Q1 earnings per share $ 0.16
Friday, 13 May 2016 

American Renal Associates Holdings Inc : Q1 net patient service operating revenues $172.1 million; q1 earnings per share $0.16 . Qtrly earnings per share $ 0.16 .American renal associates holdings, inc. Announces first quarter 2016 results.  Full Article

American Renal Associates Holdings announces closing of initial public offering
Wednesday, 27 Apr 2016 

American Renal Associates Holdings:Says closing of its initial public offering of 8,625,000 shares of common stock at an initial public offering price of $22.00 per share.Total number of shares sold in the offering includes 1,125,000 shares of common stock sold upon the exercise in full by the underwriters of their option to purchase additional shares.All of the shares in the offering were sold by ARA. ARA's common stock began trading on the New York Stock Exchange under the ticker symbol "ARA" on April 21, 2016.BofA Merrill Lynch, Barclays and Goldman, Sachs & Co. served as lead joint book-running managers and as representatives of the underwriters for the offering.Wells Fargo Securities, LLC and SunTrust Robinson Humphrey acted as joint book-running managers. Leerink Partners acted as co-manager.  Full Article

American Renal Associates Holdings, Inc. Announces Launch of Initial Public Offering
Friday, 8 Apr 2016 

American Renal Associates Holdings, Inc:Says launch of its initial public offering of 7,500,000 shares of newly issued common stock.The initial public offering price is currently estimated to be between $20 and $23 per share.ARA expects to grant the underwriters for the offering a 30-day option to purchase up to an additional 1,125,000 shares of ARA's common stock at the initial public offering price.ARA's common stock has been approved for listing on the New York Stock Exchange under the ticker symbol "ARA".BofA Merrill Lynch, Barclays and Goldman, Sachs & Co. are serving as lead joint book-running managers and as representatives of the underwriters for the offering.Wells Fargo Securities, LLC and SunTrust Robinson Humphrey are acting as joint book-running managers. Leerink Partners is acting as co-manager.  Full Article